ovarian cancer News
Most Popular ovarian cancer Story
EntreMed lands $10M deal to fund cancer drug trials
EntreMed ($ENMD) has struck a deal to bring in much-needed capital to support development of its experimental kinase inhibitor for attacking multiple types of cancer. And the Rockville, MD-based drug Read more...
Latest Headlines
- January 23, 2012
- December 21, 2011
- October 3, 2011
- August 25, 2010
- July 16, 2009
- September 15, 2008
- May 21, 2008
- January 18, 2008
- October 12, 2007
- August 29, 2007
- July 12, 2007
- January 4, 2007
- November 30, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
